Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00703040 · ClinicalTrials.gov registry record
Linkage to Care - Part I
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 35
- Enrollment target
NCT00703040: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00703040 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00703040 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
This first phase of a two-phase study involves three components: 1. Review of existing linkage-to-care protocols and sources of referrals for care; 2. Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Preference will be given to personnel with direct experience in linkage to care); and 3. Structured observations of referral sessions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-03 |
What the finished NCT00703040 record still lists
NCT00703040 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00703040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00703040 about?
NCT00703040 is a clinical study titled "Linkage to Care - Part I". This first phase of a two-phase study involves three components: 1. Review of existing linkage-to-care protocols and sources of referrals for care; 2. Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Pref...
What is the current status of trial NCT00703040?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2008-03. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT00703040?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia